A Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic Characteristics of Rocbrutinib Tablet
Clinical trial NCT07374224 · RECRUITING
Trial details
- NCT number
- NCT07374224
- Sponsor
- Guangzhou Lupeng Pharmaceutical Company LTD.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-05
- Primary completion
- 2026-06-30
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.